Saichuang Far Into the Company

Saichuang Far Into the Company

You are here: HomeProductsPentoxifylline 6493-05-6

Contact us

  • Company Name: Saichuang Far Into the Company
  • Country/region: China
  • Contact Person: Mr.chen hang
  • Tel: 86-027-50756254
  • Email:

Pentoxifylline 6493-05-6

  • CAS No:6493-05-6 3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
    Molecular Structure

    Detailed Description

    Product Name: Pentoxifylline
    Tag: Trental,Pentoxifylline,Pentox, Pentoxil and Flexital

    1. Basic Information:
    Product Name Pentoxifylline
    Synonym Trental,3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
    CAS 6493-05-6
    MF C13H18N4O3
    MW 278.31
    EINECS 229-374-5
    Assay 99%
    Quality Standards Country Standard/Pharma Grade
    Appearance White powder
    Package 20kg/Drum

    Place of Origin China
    Brand Name SMQ
    Certification ISO9001, ISO14000, KOSHER
    Model Number 6493-05-6
    MOQ 1kg
    Packaging Details 20kg/Drum, 1kg/bag
    Delivery Time 1-2 days
    Payment Terms T/T, Western union, Money gram
    Supply Ability 500000 T/Month
    2. Quick View:
    Pentoxifylline (INN, BAN, USAN) or oxpentifylline (AAN) is a drug commonly sold by Sanofi under the brand name Trental. Its chemical name is 1-(5-oxohexyl)-3, 7-dimethylxanthine. Pentoxifylline is a xanthine derivative. Other brand names include Pentox, Pentoxil and Flexital.
    3. Medical uses:
    Its primary use in medicine is in treating the symptoms of intermittent claudication resulting from peripheral artery disease. This is its only FDA, MHRA and TGA-labelled indication.
    Other indications for which the literature supports its use in include:
    (1) Multi-infarct dementia
    (2) Peyronie's disease
    (3) Sarcoidosis
    (4) Peripheral neuropathy
    (5) Sickle cell disease
    (6) Alcoholic and non-alcoholic steatohepatitis
    (7) Endometriosis
    (8) Radiation-induced fibrosis
    (9) Pentoxyphylline is also used to prevent renal toxicity in cases of alcoholic hepatitis.
    4. Mechanism:
    Like other methylated xanthine derivatives, pentoxifylline is a competitive nonselective phosphodiesterase inhibitor which raises intracellular CAMP, activates PKA, inhibits TNF and leukotriene synthesis, and reduces inflammation and innate immunity. In addition, pentoxifylline improves red blood cell deformability (known as a haemorrheologic effect), reduces blood viscosity and decreases the potential for platelet aggregation and thrombus formation. Pentoxifylline is also an antagonist at adenosine 2 receptors.
  • Pentoxifylline  6493-05-6
  • Pentoxifylline 6493-05-6